Skip to content
  • Clinical Studies
  • Pharma SOP’s
  • Pharma tips
  • Pharma Books
  • Stability Studies
  • Schedule M

Pharma GMP

Your Gateway to GMP Compliance and Pharmaceutical Excellence

  • Home
  • Quick Guide
  • GMP Failures & Pharma Compliance
    • Common GMP Failures
    • GMP Documentation & Records Failures
    • Cleaning & Sanitation Failures in GMP Audits
    • HVAC, Environmental Monitoring & Cross-Contamination Risks
  • Toggle search form

Tag: Sustainability in GMP

COFEPRIS GMP Standards and the Manufacture of Biologics in Mexico

Posted on December 13, 2024 By digi

COFEPRIS GMP Standards and the Manufacture of Biologics in Mexico COFEPRIS GMP Standards and the Manufacture of Biologics in Mexico Introduction to COFEPRIS and GMP Regulations in Mexico In Mexico, the pharmaceutical industry is regulated by the Federal Commission for the Protection against Sanitary Risks (COFEPRIS), which ensures that all pharmaceutical products meet the highest…

Read More “COFEPRIS GMP Standards and the Manufacture of Biologics in Mexico” »

GMP in Latin America (ANVISA, COFEPRIS)

Key Changes in Schedule M (Revised) GMP: What You Need to Know

Posted on December 13, 2024 By digi

Key Changes in Schedule M (Revised) GMP: What You Need to Know Understanding the Key Changes in Schedule M (Revised) GMP Guidelines Introduction to Schedule M (Revised) India’s pharmaceutical sector is one of the largest globally, and its reputation depends heavily on adherence to stringent regulatory standards. The Schedule M (Revised) guidelines under the Drugs…

Read More “Key Changes in Schedule M (Revised) GMP: What You Need to Know” »

SCHEDULE - M - Revised

TGA GMP Compliance for Small and Medium Pharma Companies in Australia

Posted on December 13, 2024 By digi

TGA GMP Compliance for Small and Medium Pharma Companies in Australia Achieving TGA GMP Compliance for Small and Medium Pharmaceutical Companies in Australia Introduction to TGA GMP Compliance The Therapeutic Goods Administration (TGA) enforces Good Manufacturing Practice (GMP) standards to ensure the quality, safety, and efficacy of pharmaceutical products in Australia. For small and medium-sized…

Read More “TGA GMP Compliance for Small and Medium Pharma Companies in Australia” »

TGA GMP Guidelines

MHRA GMP Compliance for Small and Medium Pharmaceutical Companies

Posted on December 13, 2024 By digi

MHRA GMP Compliance for Small and Medium Pharmaceutical Companies Achieving MHRA GMP Compliance for Small and Medium Pharmaceutical Companies Introduction to MHRA GMP Compliance For small and medium-sized pharmaceutical companies (SMEs), achieving and maintaining compliance with the Medicines and Healthcare products Regulatory Agency (MHRA) Good Manufacturing Practices (GMP) can be a daunting task. MHRA GMP…

Read More “MHRA GMP Compliance for Small and Medium Pharmaceutical Companies” »

MHRA GMP Guidelines

How to Achieve WHO GMP Certification in Pharmaceutical Manufacturing

Posted on December 12, 2024 By digi

How to Achieve WHO GMP Certification in Pharmaceutical Manufacturing A Step-by-Step Guide to Achieving WHO GMP Certification in Pharmaceutical Manufacturing Introduction to WHO GMP Certification The World Health Organization (WHO)’s Good Manufacturing Practices (GMP)) certification is a globally recognized standard that demonstrates a pharmaceutical manufacturer’s commitment to producing high-quality, safe, and effective medicines. Achieving WHO…

Read More “How to Achieve WHO GMP Certification in Pharmaceutical Manufacturing” »

WHO GMP Guidelines

PMDA GMP Guidelines for Biologics: Key Compliance Requirements

Posted on December 12, 2024 By digi

PMDA GMP Guidelines for Biologics: Key Compliance Requirements PMDA GMP Guidelines for Biologics: Key Compliance Requirements Introduction to PMDA GMP Guidelines for Biologics Biologics, including vaccines, monoclonal antibodies, gene therapies, and recombinant proteins, are complex pharmaceutical products derived from living organisms. Due to the intricate nature of biologic manufacturing, ensuring the safety, efficacy, and quality…

Read More “PMDA GMP Guidelines for Biologics: Key Compliance Requirements” »

PMDA GMP Guidelines

The Impact of EMA GMP Standards on the Pharmaceutical Supply Chain

Posted on December 12, 2024 By digi

The Impact of EMA GMP Standards on the Pharmaceutical Supply Chain How EMA GMP Standards Shape the Pharmaceutical Supply Chain Introduction to EMA GMP Standards and the Supply Chain The pharmaceutical supply chain is a complex network of processes involving the sourcing, production, storage, and distribution of medicinal products. The European Medicines Agency (EMA)’s Good…

Read More “The Impact of EMA GMP Standards on the Pharmaceutical Supply Chain” »

EMA GMP Guidelines

How to Prepare for a TGA GMP Inspection in Australia

Posted on December 12, 2024 By digi

How to Prepare for a TGA GMP Inspection in Australia Comprehensive Guide to Preparing for a TGA GMP Inspection in Australia Introduction to TGA GMP Inspections The Therapeutic Goods Administration (TGA) conducts Good Manufacturing Practice (GMP) inspections to ensure pharmaceutical manufacturers comply with regulatory standards. These inspections are critical for maintaining product quality, safety, and…

Read More “How to Prepare for a TGA GMP Inspection in Australia” »

TGA GMP Guidelines

How to Prepare for an NMPA GMP Inspection

Posted on December 12, 2024 By digi

How to Prepare for an NMPA GMP Inspection Preparing for an NMPA GMP Inspection: A Guide for Pharmaceutical Manufacturers Introduction to NMPA GMP Inspections The National Medical Products Administration (NMPA) is the regulatory authority responsible for ensuring that pharmaceutical products manufactured in China meet the highest standards of quality, safety, and efficacy. To maintain these…

Read More “How to Prepare for an NMPA GMP Inspection” »

NMPA GMP Guidelines

How to Prepare for Schedule M (Revised) GMP Inspections in India

Posted on December 12, 2024 By digi

How to Prepare for Schedule M (Revised) GMP Inspections in India Effective Preparation for Schedule M (Revised) GMP Inspections in India Understanding Schedule M (Revised) Inspections In the Indian pharmaceutical industry, Schedule M (Revised) under the Drugs and Cosmetics Act, 1940, establishes comprehensive guidelines for Good Manufacturing Practices (GMP). Regulatory inspections are a critical component…

Read More “How to Prepare for Schedule M (Revised) GMP Inspections in India” »

SCHEDULE - M - Revised

Posts pagination

Previous 1 … 41 42 43 … 50 Next

Quick Guide

  • GMP Basics
    • Introduction to GMP
    • What is cGMP?
    • Key Principles of GMP
    • Benefits of GMP in Pharmaceuticals
    • GMP vs. GxP (Good Practices)
  • Regulatory Agencies & Guidelines
    • WHO GMP Guidelines
    • FDA GMP Guidelines
    • MHRA GMP Guidelines
    • SCHEDULE – M – Revised
    • TGA GMP Guidelines
    • Health Canada GMP Regulations
    • NMPA GMP Guidelines
    • PMDA GMP Guidelines
    • EMA GMP Guidelines
  • GMP Compliance & Audits
    • How to Achieve GMP Certification
    • GMP Auditing Process
    • Preparing for GMP Inspections
    • Common GMP Violations
    • Role of Quality Assurance
  • Quality Management Systems (QMS)
    • Building a Pharmaceutical QMS
    • Implementing QMS in Pharma Manufacturing
    • CAPA (Corrective and Preventive Actions) for GMP
    • QMS Software for Pharma
    • Importance of Documentation in QMS
    • Integrating GMP with QMS
  • Pharmaceutical Manufacturing
    • GMP in Drug Manufacturing
    • GMP for Biopharmaceuticals
    • GMP for Sterile Products
    • GMP for Packaging and Labeling
    • Equipment and Facility Requirements under GMP
    • Validation and Qualification Processes in GMP
  • GMP Best Practices
    • Total Quality Management (TQM) in GMP
    • Continuous Improvement in GMP
    • Preventing Cross-Contamination in Pharma
    • GMP in Supply Chain Management
    • Lean Manufacturing and GMP
    • Risk Management in GMP
  • Regulatory Compliance in Different Regions
    • GMP in North America (FDA, Health Canada)
    • GMP in Europe (EMA, MHRA)
    • GMP in Asia (PMDA, NMPA, KFDA)
    • GMP in Emerging Markets (GCC, Latin America, Africa)
    • GMP in India
  • GMP for Small & Medium Pharma Companies
    • Implementing GMP in Small Pharma Businesses
    • Challenges in GMP Compliance for SMEs
    • Cost-effective GMP Compliance Solutions for Small Pharma Companies
  • GMP in Clinical Trials
    • GMP Compliance for Clinical Trials
    • Role of GMP in Drug Development
    • GMP for Investigational Medicinal Products (IMPs)
  • International GMP Inspection Standards and Harmonization
    • Global GMP Inspection Frameworks
    • WHO Prequalification and Inspection Systems
    • US FDA GMP Inspection Programs
    • EMA and EU GMP Inspection Practices
    • PIC/S Role in Harmonized Inspections
    • Country-Specific Inspection Standards (e.g., UK MHRA, US FDA, TGA)
  • GMP Blog

Latest Posts

  • GMP-cGMP Regulations & Global Standards
    • FDA cGMP Regulations for Drugs & Biologics
    • cGMP Requirements for Pharmaceutical Manufacturers
    • ICH Q7 and API GMP Expectations
    • Global & ISO-Based GMP Standards
    • GMP for Medical Devices & Combination Products
    • GMP for Pharmacies & Hospital Pharmacy Settings
  • Applied GMP in Pharma Manufacturing & Operations
    • GMP for Pharmaceutical Drug Product Manufacturing
    • GMP for Biotech & Biologics Manufacturing
    • GMP Documentation
    • GMP Compliance
    • GMP for APIs & Bulk Drugs
    • GMP Training
  • Computer System Validation (CSV) & GxP Computerized Systems
    • CSV Fundamentals in Pharma & Biotech
    • FDA CSV Guidance & 21 CFR Part 11 Alignment
    • GAMP 5 & Risk-Based Validation Approaches
    • CSV in Pharmaceutical & GxP Industries (Use-Cases & System Types)
    • CSV Documentation
    • CSV for Regulated Equipment & Embedded Systems
  • Data Integrity & 21 CFR Part 11 Compliance
    • Data Integrity Principles in cGMP Environments
    • FDA Data Integrity Guidance & Expectations
    • 21 CFR Part 11 – Electronic Records & Signatures
    • Data Integrity in GxP Computerized Systems
    • Data Integrity Audits
  • Pharma GMP & Good Manufacturing Practice
    • FDA 483, Warning Letters & GMP Inspections
    • Data Integrity, ALCOA+ & Part 11 / Annex 11
    • Process Validation, CPV & Cleaning Validation
    • Contamination Control & Annex 1
    • PQS / QMS / Deviations / CAPA / OOS–OOT
    • Documentation, Batch Records & GDP
    • Sterility, Microbiology & Utilities
    • CSV, GAMP 5 & Automation
    • Dosage-Form–Specific GMP (Solids, Liquids, Sterile, Topicals)
    • Supply Chain, Warehousing, Cold Chain & GDP
Widget Image
  • Never Assign Batch Release Responsibilities to Non-QA Personnel in GMP

    Never Assign Batch Release Responsibilities… Read more

  • Manufacturing & Batch Control
    • GMP manufacturing process control
    • Batch Manufacturing record requirements
    • Master Batch record template for pharmaceuticals
    • In Process control checks in tablet manufacturing
    • Line clearance procedure before batch start
    • Batch reconciliation in pharmaceutical manufacturing
    • Yield reconciliation GMP guidelines
    • Segregation of different strength products GMP
    • GMP controls for high potency products
    • Cross Contamination prevention in manufacturing
    • Line clearance checklist for production
    • Batch documentation review before qa release
    • Process parameters control limits in pharma
    • Equipment changeover procedure GMP
    • Batch manufacturing deviation handling
    • GMP expectations for batch release
    • In Process sampling plan for tablets
    • Visual inspection of dosage forms GMP requirements
    • In Process checks for filled vials
    • Startup and Shutdown procedure for manufacturing line
    • GMP requirements for blending and mixing operations
    • Process Control strategy in pharmaceutical manufacturing
    • Uniformity of dosage units in process controls
    • GMP checklist for oral solid dosage manufacturing
    • Process Control
    • Batch Documentation
    • Master Batch Records
    • In-Process Controls
    • Line Clearance
    • Yield & Reconciliation
    • Segregation & Mix-Ups
    • High Potency Products
    • Cross Contamination Control
    • Line Clearance
    • Batch Review
    • Process Parameters
    • Equipment Changeover
    • Deviations
    • Batch Release
    • In-Process Sampling
    • Visual Inspection
    • In-Process Checks for Vials
    • Start-Up & Shutdown
    • Blending & Mixing
    • Control Strategy
    • Dosage Uniformity
    • Hold Time Studies
    • OSD GMP Checklist
  • Cleaning & Contamination Control
  • Warehouse & Material Handling
    • Warehouse GMP
    • Material Receipt
    • Sampling
    • Status Labelling
    • Storage Conditions
    • Rejected & Returned
    • Reconciliation
    • Controlled Drugs
    • Dispensing
    • FIFO & FEFO
    • Cold Chain
    • Segregation
    • Pest Control
    • Env Monitoring
    • Palletization
    • Damaged Containers
    • Stock Verification
    • Sampling & Weighing Areas
    • Issue to Production
    • Traceability
    • Printed Materials
    • Intermediates
    • Cleaning & Housekeeping
    • Status Tags
    • Warehouse Audit
  • QC Laboratory & Testing
    • Analytical Method Validation
    • Chromatography Systems
    • Dissolution Testing
    • Assay & CU
    • Impurity Profiling
    • Stability & QC
    • OOS Investigations
    • OOT Trending
    • Sample Management
    • Reference Standards
    • Equipment Calibration
    • Instrument Qualification
    • LIMS & Electronic Data
    • Data Integrity
    • Microbiology QC
    • Sterility & Endotoxin
    • Environmental Monitoring
    • QC Documentation
    • Results Review
    • Method Transfer
    • Forced Degradation
    • Compendial Methods
    • Cleaning Verification
    • QC Deviations & CAPA
    • QC Lab Audits
  • Manufacturing & In-Process Control
    • Batch Manufacturing Records
    • Batch Manufacturing Records
    • Line Clearance
    • In-Process Sampling & Testing
    • Yield & Reconciliation
    • Granulation Controls
    • Blending & Mixing
    • Tablet Compression Controls
    • Capsule Filling Controls
    • Coating Process Controls
    • Sterile & Aseptic Processing
    • Filtration & Sterile Filtration
    • Visual Inspection of Parenteral
    • Packaging & Labelling Controls
    • Rework & Reprocessing
    • Hold Time for Bulk & Intermediates
    • Manufacturing Deviations & CAPA
  • Documentation, Training & QMS
    • SOP & Documentation Control
    • Training & Competency Management
    • Change Control & QMS Lifecycle
    • Internal Audits & Self-Inspection
    • Quality Metrics, Risk & Management Review
  • Production SOPs
  • QC Laboratory SOPs
    • Sample Management
    • Analytical Methods
    • HPLC & Chromatography
    • OOS & OOT
    • Data Integrity
    • Documentation
    • Equipment
  • Warehouse & Materials SOPs
    • Material Receipt
    • Sampling
    • Storage
    • Dispensing
    • Rejected & Returned
    • Cold Chain
    • Stock Control
    • Printed Materials
    • Pest & Housekeeping
  • Cleaning & Sanitization SOPs
  • Equipment & Qualification SOPs
  • Documentation & Data Integrity SOPs
  • Deviation/OOS/CAPA SOPs
    • Deviation Management
    • Root Cause
    • CAPA
    • OOS/OOT
    • Complaints
    • Recall
  • Training & Competency SOPs
    • Training System
    • Role-Based Training
    • OJT
    • Refresher Training
    • Competency
  • QA & QMS Governance SOPs
    • Quality Manual
    • Management Review
    • Internal Audit
    • Risk Management
    • Vendors & Outsourcing
  • About Us
  • Privacy Policy & Disclaimer
  • Contact Us

Copyright © 2025 Pharma GMP.

Powered by PressBook WordPress theme